Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg D Sacks

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Annals of Surgery|May 19, 2016
Surgeon Perception of Risk and Benefit in the Decision to OperateGreg D Sacks, Aaron J Dawes, Susan L Ettner, et al.
Annals of Surgery|May 29, 2024
Quantifying Patient Risk Threshold in Managing Pancreatic Intraductal Papillary Mucinous NeoplasmsSarah R Kaslow, Acacia R Sharma, D Brock Hewitt, et al.
BMJ Quality & Safety|May 24, 2015
Teamwork, communication and safety climate: a systematic review of interventions to improve surgical cultureGreg D Sacks, Evan M Shannon, Aaron J Dawes, et al.
Annals of Surgery|December 24, 2025
Transitional Type Circulating Tumor Cells Predict Systemic Recurrence and Support Risk Stratification for Chemotherapy After Resection of Pancreatic Ductal Adenocarcinoma: Long-term Outcomes of the CLUSTER TrialIngmar F Rompen, Joseph R Habib, Alessio Marchetti, et al.
Surgery|February 6, 2016
Long-term survival in patients with pancreatic ductal adenocarcinomaAlexander P Stark, Greg D Sacks, Matthew M Rochefort, et al.
Annals of Surgery|February 22, 2023
The Influence of Patient Preference on Surgeons' Treatment Recommendations in the Management of Intraductal Papillary Mucinous NeoplasmsGreg D Sacks, Paul Shin, R Scott Braithwaite, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 6, 2024
Identifying an optimal cancer risk threshold for resection of pancreatic intraductal papillary mucinous neoplasmsGreg D Sacks, Luke Wojtalik, Sarah R Kaslow, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 3, 2026
Clinical and molecular features of resected early onset pancreatic ductal adenocarcinoma: insights from the NCDB and cBioPortalNabiha A Mughal, Omar Mahmud, Ingmar F Rompen, et al.
Annals of Surgery|October 5, 2023
Risk Perceptions and Risk Thresholds Among Surgeons in the Management of Intraductal Papillary Mucinous NeoplasmsGreg D Sacks, Paul Shin, R Scott Braithwaite, et al.
Journal of the American College of Surgeons|December 19, 2025
Proposal for an Objective and Concrete Definition for Determining Anatomic Resectability in Pancreatic Cancer: The Concept of the "Suitable Target"Alessio Marchetti, Jonathan Garnier, Giampaolo Perri, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Annals of Surgery|May 19, 2016
Surgeon Perception of Risk and Benefit in the Decision to OperateGreg D Sacks, Aaron J Dawes, Susan L Ettner, et al.
Annals of Surgery|May 29, 2024
Quantifying Patient Risk Threshold in Managing Pancreatic Intraductal Papillary Mucinous NeoplasmsSarah R Kaslow, Acacia R Sharma, D Brock Hewitt, et al.
BMJ Quality & Safety|May 24, 2015
Teamwork, communication and safety climate: a systematic review of interventions to improve surgical cultureGreg D Sacks, Evan M Shannon, Aaron J Dawes, et al.
Annals of Surgery|December 24, 2025
Transitional Type Circulating Tumor Cells Predict Systemic Recurrence and Support Risk Stratification for Chemotherapy After Resection of Pancreatic Ductal Adenocarcinoma: Long-term Outcomes of the CLUSTER TrialIngmar F Rompen, Joseph R Habib, Alessio Marchetti, et al.
Surgery|February 6, 2016
Long-term survival in patients with pancreatic ductal adenocarcinomaAlexander P Stark, Greg D Sacks, Matthew M Rochefort, et al.
Annals of Surgery|February 22, 2023
The Influence of Patient Preference on Surgeons' Treatment Recommendations in the Management of Intraductal Papillary Mucinous NeoplasmsGreg D Sacks, Paul Shin, R Scott Braithwaite, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 6, 2024
Identifying an optimal cancer risk threshold for resection of pancreatic intraductal papillary mucinous neoplasmsGreg D Sacks, Luke Wojtalik, Sarah R Kaslow, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 3, 2026
Clinical and molecular features of resected early onset pancreatic ductal adenocarcinoma: insights from the NCDB and cBioPortalNabiha A Mughal, Omar Mahmud, Ingmar F Rompen, et al.
Annals of Surgery|October 5, 2023
Risk Perceptions and Risk Thresholds Among Surgeons in the Management of Intraductal Papillary Mucinous NeoplasmsGreg D Sacks, Paul Shin, R Scott Braithwaite, et al.
Journal of the American College of Surgeons|December 19, 2025
Proposal for an Objective and Concrete Definition for Determining Anatomic Resectability in Pancreatic Cancer: The Concept of the "Suitable Target"Alessio Marchetti, Jonathan Garnier, Giampaolo Perri, et al.
Pageof 10